Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Lixte Biotechnology Holdings Inc (LIXT)

NASDAQ
Currency in USD
Disclaimer
1.860
+0.040(+2.20%)
Closed
LIXT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.8601.910
52 wk Range
1.5504.420
Prev. Close
1.82
Open
1.91
Day's Range
1.86-1.91
52 wk Range
1.55-4.42
Volume
1,666
Average Volume (3m)
52,610
1-Year Change
-30.08%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
LIXT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Lixte Biotechnology Holdings Inc Company Profile

LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colon cancer. The company’s Phase 1b portion of its advanced soft tissue sarcoma clinical trial seeks to determine appropriate dosing and toxicity for treating soft tissue sarcomas with combination of LB-100 and standard-of-care chemotherapy; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

Compare LIXT to Peers and Sector

Metrics to compare
LIXT
Peers
Sector
Relationship
P/E Ratio
−1.0x−2.4x−0.6x
PEG Ratio
−0.02−0.020.00
Price/Book
−3.3x4.5x2.6x
Price / LTM Sales
-109.4x3.2x
Upside (Analyst Target)
-168.8%43.9%
Fair Value Upside
Unlock−33.4%7.8%Unlock

FAQ

What Is the Lixte Bio (LIXT) Stock Price Today?

The Lixte Bio stock price today is 1.86

What Stock Exchange Does Lixte Bio Trade On?

Lixte Bio is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Lixte Bio?

The stock symbol for Lixte Bio is "LIXT."

What Is the Lixte Bio Market Cap?

As of today, Lixte Bio market cap is 4.18M.

What is Lixte Bio Earnings Per Share?

The Lixte Bio EPS is -1.83.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.